Inhibition of Acute Rejection After Skin or Cardiac Transplantation by Administration of Donor Antigens in the Rat

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Surgery today (Print)

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00595-003-2701-5PMID 15052450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Limited effectiveness of FK506 administration for ongoing rejection in heterotopic rat heart transplantation

  2005cited by this paper
• Steroid-free maintenance immunosuppression after heart transplantation.

  2001cited by this paper
• Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation.

  1999cited by this paper
• Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.

  1999cited by this paper
• Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes

  1999cited by this paper
• Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat.

  1999cited by this paper
• Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes.

  1999cited by this paper
• Prolongation of survival of primary renal allografts by feeding of donor spleen cells.

  1998cited by this paper
• CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.

  1997cited by this paper
• Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.

  1997cited by this paper
• A subset of γδ T‐cell receptor‐positive cells produce T‐helper type‐2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization

  1996cited by this paper
• Prevention and reversal of renal allograft rejection by antibody against CD45RB

  1996cited by this paper
• Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

  1996cited by this paper
• Treatment of autoimmune disease by oral tolerance to autoantigens.

  1996cited by this paper
• Gamma delta TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo.

  1996cited by this paper
• Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.

  1995cited by this paper
• Changes in the mononuclear cell subpopulations of rat cardiac transplant recipients administered FK506 for the treatment of ongoing rejection

  1995cited by this paper
• Peripheral deletion of antigen-reactive T cells in oral tolerance

  1995cited by this paper
• Peripheral deletion of antigen-reactive T cells in oral tolerance

  1995cited by this paper
• Role of Micro-Chimerism in Inducing Immunological Tolerance by Intraportal Injection of Donor Spleen Cells in Rats

  1995cited by this paper
• Regulation of IFN-gamma and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts.

  1995cited by this paper
• The effect of transfusion with donor-specific peripheral lymphocytes, whole blood or erythrocytes on cardiac allograft survival in cyclosporine-treated rats.

  1994cited by this paper
• Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation for the mechanism of tolerance induction by portal vein injection

  1994cited by this paper
• Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.

  1993cited by this paper
• Efficacy of perioperative portal venous inoculation with donor lymphocytes on skin graft survivals in the rat.

  1993cited by this paper
• Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats.

  1992cited by this paper
• Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats

  1992cited by this paper
• The blood transfusion effect: experimental aspects.

  1991cited by this paper
• The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum.

  1990cited by this paper
• The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. II. Phenotypic and functional analyses of graft-infiltrating cells.

  1990cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper
• FK 506 for liver, kidney, and pancreas transplantation.

  1989cited by this paper
• Analysis of morbid events and risk factors for death after cardiac transplantation.

  1988cited by this paper
• Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats.

  1988cited by this paper
• INDUCTION OF DONOR‐SPECIFIC UNRESPONSIVENESS TO RAT CARDIAC ALLOGRAFT BY DONOR LEUKOCYTES AND CYCLOSPORINE

  1988cited by this paper
• The influence of surgical operations on components of the human immune system

  1985cited by this paper
• [Immunological studies on renal transplantation in rats. Effects of pretransplant blood transfusion on renal graft survival].

  1985cited by this paper
• Prolongation of rat islet allograft survival by direct ultraviolet irradiation of the graft.

  1984cited by this paper
• Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusions.

  1981cited by this paper
• Deliberate Donor‐specific Blood Transfusions Prior to Living Related Renal Transplantation: A New Approach

  1980cited by this paper
• Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.

  1979cited by this paper
• Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS.

  1979cited by this paper
• PROLONGATION OF ISLET ALLOGRAFT SURVIVAL

  1979cited by this paper
• Effect of blood transfusions on subsequent kidney transplants.

  1973cited by this paper
• THE EFFECT OF DONOR STRAIN BLOOD PRETREATMENT ON RENAL ALLOGRAFT REJECTION IN RATS

  1972cited by this paper
• Improved technique of heart transplantation in rats.

  1969cited by this paper
• Inhibition of Experimental Drug Allergy by Prior Feeding of the Sensitizing Agent

  1946cited by this paper

• Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.

  2009cites this paper